A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes

NCT03861052 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

636

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Tirzepatide
DRUG: Dulaglutide

Sponsor

Eli Lilly and Company